07 February 2021 : Review article
A Review of the Current Practice of Diagnosis and Treatment of Idiopathic Membranous Nephropathy in China
DOI: 10.12659/MSM.930097
Med Sci Monit 2021; 27:e930097
Background
Research Progress in the Pathogenesis of IMN
Experimental Animal Models
Complement Activation and IMN
New Diagnostic Biomarkers
Genetic Background
Treatment of IMN
Renin-Angiotensin System Inhibitors
Glucocorticoids
Cyclophosphamide
Calcineurin Inhibitors
Adrenocorticotropic Hormone
Rituximab Therapy
Mycophenolate Mofetil
Traditional Chinese Medicine
New Approaches and Remaining Clinical Challenges
Conclusions
References